LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 33.32 | 84.90 | 1180 | 2722 | 0.4334 | 0.6922 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 35.03 | 84.90 | 907 | 2991 | 0.3032 | 0.5856 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 35.03 | 84.90 | 967 | 2991 | 0.3233 | 0.6054 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 35.03 | 84.90 | 71 | 2991 | 0.0237 | -0.0342 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 35.03 | 84.90 | 1190 | 2991 | 0.3978 | 0.6716 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.73 | 84.90 | 952 | 3254 | 0.2925 | 0.5833 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.73 | 84.90 | 1009 | 3254 | 0.3101 | 0.6009 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.73 | 84.90 | 76 | 3254 | 0.0234 | -0.0208 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 36.73 | 84.90 | 1215 | 3254 | 0.3734 | 0.6584 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.43 | 84.90 | 992 | 3459 | 0.2867 | 0.5834 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.43 | 84.90 | 1043 | 3459 | 0.3015 | 0.5984 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.43 | 84.90 | 71 | 3459 | 0.0205 | -0.0329 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 38.43 | 84.90 | 1232 | 3459 | 0.3561 | 0.6489 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.14 | 84.90 | 1014 | 3682 | 0.2754 | 0.5778 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.14 | 84.90 | 1056 | 3682 | 0.2868 | 0.5896 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.14 | 84.90 | 72 | 3682 | 0.0196 | -0.0298 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 40.14 | 84.90 | 1147 | 3682 | 0.3115 | 0.6140 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 41.84 | 84.90 | 1026 | 4003 | 0.2563 | 0.5656 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 41.84 | 84.90 | 1072 | 4003 | 0.2678 | 0.5780 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 41.84 | 84.90 | 74 | 4003 | 0.0185 | -0.0244 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 41.84 | 84.90 | 1166 | 4003 | 0.2913 | 0.6020 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 43.55 | 84.90 | 1010 | 4287 | 0.2355 | 0.5490 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 43.55 | 84.90 | 1054 | 4287 | 0.2458 | 0.5607 | MN20160318_Q02 | F07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 43.55 | 84.90 | 83 | 4287 | 0.0194 | -0.0040 | MN20160318_Q02 | J22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.1 | 43.55 | 84.90 | 1187 | 4287 | 0.2768 | 0.5939 | MN20160318_Q02 | J22 |